semaglutide cardiovascular outcomes news 2025 october SOUL (Semaglutide cardiOvascular oUtcomes triaL) in individuals with Weight loss and cardiovascular disease

Why Protein Intake Matters on GLP-1 Medications One of the main effects of GLP-1 medications is a decrease in appetite

Can oral chemotherapy cause liver or heart problems

Glutamate transporters are necessary for clearing excess glutamate from the synaptic cleft to prevent excitotoxicity ( Not only can excitotoxicity and oxidative stress lead to neuroinflammation, but neuroinflammation caused by trauma, stress, or infiltration of peripheral cytokines, can also independently cause both excitotoxicity and oxidative stress ( In summary, the neurotoxic triad is self-perpetuating, with each component able to support the propagation of the others

Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, has shown promise in the treatment of type 2 diabetes and obesity